CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Rising focus on improving the quality of patient care
4.1.2. Regulatory requirements
4.1.3. Increasing awareness and industry initiatives for radiation dose management
4.2. Market Restraints & Challenges
4.2.1. Lack of reimbursement for adopting radiation dose management solutions
4.2.2. Lack of benchmarking for dose optimisation across the globe
4.2.3. Lack of knowledge of these solutions as well as skilled labour
4.3. Market Opportunities
4.3.1. Technological advancements
4.3.2. Growing focus on interventional radiology and nuclear medicine
CHAPTER 5. GLOBAL RADIATION DOSE MANAGEMENT MARKET – BY
PRODUCTS & SERVICES
5.1. Introduction
5.2. Radiation Dose Management Solutions
5.2.1. Standalone Solutions
5.2.2. Integrated Solutions
5.3. Radiation Dose Management Services Market
5.3.1. Support & Maintenance Services
5.3.2. Consulting Services
5.3.3. Implementation & Integration Services
5.3.4. Education & Training Services
CHAPTER 6. GLOBAL RADIATION DOSE MANAGEMENT MARKET – BY
MODALITY
6.1. Introduction
6.2. Computed Tomography
6.3. Radiography and Mammography
6.4. Fluoroscopy and Interventional Imaging
6.5. Nuclear Medicine
CHAPTER 7. GLOBAL RADIATION DOSE MANAGEMENT MARKET – BY END
USER
7.1 Introduction
7.2 Hospitals
7.3 Ambulatory Care Settings
7.4 Research Institutes and Academic Medical Centers
CHAPTER 8. GLOBAL RADIATION DOSE MANAGEMENT MARKET - BY
GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.2.4. Costa Rica
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Chile
8.3.4. Columbia
8.3.5. Others
8.4. Europe
8.4.1. U.K.
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Netherlands
8.4.8. Switzerland
8.4.9. Poland
8.4.10. Others
8.5. APAC
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. South Korea
8.5.5. Australia & New Zealand
8.5.6. Malaysia
8.5.7. Singapore
8.5.8. Others
8.6. Middle East & Africa
8.6.1. UAE
8.6.2. Saudi Arabia
8.6.3. Iran
8.6.4. Iraq
8.6.5. Qatar
8.6.6. South Africa
8.6.7. Algeria
8.6.8. Morocco
8.6.9. Nigeria
8.6.10. Egypt
8.6.11. Others
CHAPTER 9. GLOBAL RADIATION DOSE MANAGEMENT MARKET - COMPANY
PROFILES
9.1. Bayer AG
9.2. Pacshealth, LLC
9.3. GE Healthcare
9.4. Sectra AB
9.5. Philips Healthcare
9.6. Siemens Healthineers (A Division of Siemens AG)
9.7. Agfa HealthCare
9.8. Novarad Corporation
9.9. Fujifilm Holdings Corporation
9.10. Bracco Imaging S.P.A.
9.11. Medsquare SAS
9.12. Qaelum N.V.
9.13. Infinitt Healthcare Co., Ltd
9.14. Thermo Fisher Scientific
9.15. Landauer, Inc
CHAPTER 10. GLOBAL RADIATION DOSE MANAGEMENT MARKET
COMPETITIVE LANDSCAPE
10.1. Market Share Analysis
10.2. Strategies adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 11. MARKET INSIGHTS
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
CHAPTER 12. APPENDIX
12.1. List of Tables
12.2. List of Figures
